Repository logo
 
Publication

Implementation of humane endpoints on bladder cancer research

2014Conference object Restricted access
Simple item page
dc.contributor.authorOliveira, MC
dc.contributor.authorFaustino-Rocha, AI
dc.contributor.authorVala, Helena
dc.contributor.authorOliveira, PA
dc.date.accessioned2015-03-23T11:25:39Z
dc.date.available2015-03-23T11:25:39Z
dc.date.issued2014
dc.description.abstractObjective: Pain, distress, or discomfort should be minimized during experimental procedures using animals. The goal of this work was to establish humane endpoints for a model of bladder cancer chemically-induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN). Methods: Procedures were made in accordance with the European Directive 2010/63/EU. Twelve Wistar rats were used. The carcinogen agent BBN was administered in drinking water during 20 weeks. After this, they consumed only water until 35 weeks of the experimental protocol. During the protocol was used a scoring sheet where biological variables were registered daily to monitor animal welfare. Results: No animals died during the experimental protocol. Four animals showed signs of haematuria since the fifteenth week after the beginning of the experiment, these animals also exhibited moderate anemia in the last week of the protocol that was evident through the mucosal observations. All animals exhibited a mental status, eyes, ears and whiskers position, response to handling, breathing and hydration within the parameters considered normal for the specie. Conclusion: The animals did not show clinical signs compatible to suffering that justified their sacrifice before the end of the study. The endpoints established for this model are adequate to bladder cancer studies once no endpoints were reached.por
dc.description.sponsorshipFCT (PTDC/DES/114122/2009) and CI&DETS (PEst-OE/CED/UI4016)por
dc.identifier.citationOliveira MC, Faustino-Rocha AI, Vala H, Oliveira PA (2014). Implementation of humane endpoints on bladder cancer research. Virchows Arch 465 (Supll I): S161 IF 2012 2.676por
dc.identifier.urihttp://hdl.handle.net/10400.19/2731
dc.language.isoengpor
dc.peerreviewedyespor
dc.subjectbladder cancerpor
dc.subjectN-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)por
dc.titleImplementation of humane endpoints on bladder cancer researchpor
dc.typeconference object
dspace.entity.typePublication
oaire.citation.titleVirchows Archpor
oaire.citation.volume465 (Supll I)por
person.familyNameVala Correia
person.givenNameHelena Maria
person.identifier.ciencia-id7A1E-E85E-FFA4
person.identifier.orcid0000-0001-6829-4867
rcaap.rightsrestrictedAccesspor
rcaap.typeconferenceObject
relation.isAuthorOfPublicationcdc3d2e2-df06-40ed-8900-1ecbc8a06c8a
relation.isAuthorOfPublication.latestForDiscoverycdc3d2e2-df06-40ed-8900-1ecbc8a06c8a

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
51 Implementation of endpoints on bladder cancer ESP 14.pdf
Size:
1.68 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

ESAV - DZERV - Documentos de congressos (comunicações, posters, actas)